Characteristics of AIH patients assayed by PhIP-seq (n = 115)
| . | Mean ALT . | Mean AST . | Mean IgG . | Advanced fibrosis (F3/F4) . | Steroid-containing regimen . | Nonsteroid regimen . | No reported treatmenta . | Anti-SMA positive . |
|---|---|---|---|---|---|---|---|---|
| AIH | 79 | 66 | 1,520 | 58% | 46% | 34% | 20% | 81% |
| . | Mean ALT . | Mean AST . | Mean IgG . | Advanced fibrosis (F3/F4) . | Steroid-containing regimen . | Nonsteroid regimen . | No reported treatmenta . | Anti-SMA positive . |
|---|---|---|---|---|---|---|---|---|
| AIH | 79 | 66 | 1,520 | 58% | 46% | 34% | 20% | 81% |
Anti-SMA, anti-smooth muscle antibodies.
6% of patients were reported as being off all treatment, and an additional 14% of patients did not have a treatment regimen reported.